Company Overview
Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as
an exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses, or an “initial business combination.”
Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region although we intent to focus our search for business combination targets in the pharmaceutical industry.
an exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses, or an “initial business combination.”
Our efforts to identify a prospective target business will not be limited to a particular industry or geographic region although we intent to focus our search for business combination targets in the pharmaceutical industry.
Current Status
On January 29, 2025, we consummated our initial public offering. Net proceeds of $231,150,000 have been placed in a trust account established for the benefit of the Company's public shareholders and that we may use to complete our initial business combination.
Focus Sectors
While we may pursue an acquisition opportunity in any industry or sector, we intend to focus on businesses in the plant-based pharmaceutical and manufacturing sectors which complements our management team’s expertise and will benefit from our strategic and hands-on operational leadership.
Management Team Expertise
We believe that the experience and capabilities of our management team will make us an attractive partner to potential target businesses, enhance our ability to complete a successful business combination, and bring value to the business's post-business combination.
Track Record of Success
Our management team represents a unique combination of operating, investing, financial and transactional experience. This group has a strong track record of creating value for shareholders in multiple pharmaceutical, medical, and agricultural sectors that they have led, managed and/or invested in.